首页> 外文期刊>U. S. pharmacist >Drug Costs in Medicare Dollars and Cost-Related Nonadherence
【24h】

Drug Costs in Medicare Dollars and Cost-Related Nonadherence

机译:Medicare美元的药物成本和与成本相关的非正规

获取原文
获取原文并翻译 | 示例
           

摘要

The costs of prescription drugs continue to increase in the United States. Medicare prescription drug coverage-Medicare Part D, the major source of payment for prescription drugs for people aged 65 years and older-remains complex and dynamic.1'2 The estimated expenditure for Medicare Part D, made by the Congressional Budget Office, is expected to total $99 billion in 2019, accounting for 15% of net Medicare outlays.3 Overall, Medicare's share of retail prescription-drug spending has increased from 18% in 2006 to 30% in 2017.4 As a major payer for retail prescription drugs, Medicare is second only to private insurance.
机译:处方药的成本在美国继续增加。 Medicare处方药覆盖范围 - Medicare Dials D,65岁人员的处方药支付主要来源和较老的复杂性和动态。 2019年总计990亿美元,占净医疗费用的15%总体而言,Medicare的零售处方药支出的份额从2006年的18%增加到2017年的18%至30%.4作为零售处方药,Medicare的主要付款人 仅次于私人保险。

著录项

  • 来源
    《U. S. pharmacist》 |2019年第6期|共4页
  • 作者

    Mary Ann E. Zajaria;

  • 作者单位

    Clinical Consultant Pharmacist and President of MZ Associates Inc. Hallowell Maine;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号